NASDAQ:LHCGLHC Group Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding LHC Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $199.80 +1.57 (+0.79 %) (As of 08/4/2020 04:00 PM ET) Add Compare Share Today's Range$196.28Now: $199.80▼$201.4150-Day Range$157.88MA: $179.41▼$198.2352-Week Range$100.00Now: $199.80▼$201.41Volume189,994 shsAverage Volume205,952 shsMarket Capitalization$6.31 billionP/E Ratio63.23Dividend YieldN/ABeta0.52 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including skilled nursing, private duty nursing, physical, occupational and speech therapy, medically-oriented social services and hospice care. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel by operating an institutional pharmacy, which focuses on providing a full array of services to long term acute care hospitals. The Healthcare Innovations segment reports on developmental activities outside its other business segments, which provides primary medical care for patients with chronic and acute illnesses who have difficulty traveling to a doctor's office. LHC Group was founded by Keith G. Myers in September 1994 and is headquartered in Lafayette, LA.Read More Beat the Market (BTM) Rank™ 1.4 Analyst's Opinion Consensus RatingLHC Group has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 8 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $165.67, LHC Group has a potential downside of 17.1% from its current price of $199.80.Amount of Analyst CoverageLHC Group has only been the subject of 4 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesLHC Group has received 356 “outperform” votes. (Add your “outperform” vote.)Underperform VotesLHC Group has received 369 “underperform” votes. (Add your “underperform” vote.)Community SentimentLHC Group has received 50.90% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about LHC Group and other stocks. Vote “Outperform” if you believe LHCG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LHCG will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldLHC Group does not currently pay a dividend.Dividend GrowthLHC Group does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LHC Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.80% of the stock of LHC Group is held by insiders.Percentage Held by Institutions94.55% of the stock of LHC Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for LHC Group are expected to grow by 27.93% in the coming year, from $4.26 to $5.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LHC Group is 63.23, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 17.49.Price to Earnings Ratio vs. SectorThe P/E ratio of LHC Group is 63.23, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.25.Price to Earnings Growth RatioLHC Group has a PEG Ratio of 3.59. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioLHC Group has a P/B Ratio of 4.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.4Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.23 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Home health care services Sub-IndustryHealth Care Services SectorMedical Current SymbolNASDAQ:LHCG Previous Symbol CUSIP50187A10 CIK1303313 Webwww.lhcgroup.com Phone337-233-1307Debt Debt-to-Equity Ratio0.24 Current Ratio1.74 Quick Ratio1.74Price-To-Earnings Trailing P/E Ratio63.23 Forward P/E Ratio46.90 P/E Growth3.65 Sales & Book Value Annual Sales$2.08 billion Price / Sales3.03 Cash Flow$6.11 per share Price / Cash Flow32.71 Book Value$47.83 per share Price / Book4.18Profitability EPS (Most Recent Fiscal Year)$4.47 Net Income$95.73 million Net Margins4.73% Return on Equity8.89% Return on Assets6.23%Miscellaneous Employees30,399 Outstanding Shares31,590,000Market Cap$6.31 billion Next Earnings Date8/5/2020 (Confirmed) OptionableOptionable $199.80 +1.57 (+0.79 %) (As of 08/4/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive LHCG News and Ratings via Email Sign-up to receive the latest news and ratings for LHCG and its competitors with MarketBeat's FREE daily newsletter. LHC Group (NASDAQ:LHCG) Frequently Asked Questions How has LHC Group's stock been impacted by COVID-19 (Coronavirus)? LHC Group's stock was trading at $127.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LHCG shares have increased by 57.3% and is now trading at $199.80. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of LHC Group? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for LHC Group. When is LHC Group's next earnings date? LHC Group is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for LHC Group. How were LHC Group's earnings last quarter? LHC Group, Inc. (NASDAQ:LHCG) released its quarterly earnings results on Thursday, May, 7th. The health services provider reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.06. The health services provider earned $512.90 million during the quarter, compared to analysts' expectations of $504.41 million. LHC Group had a net margin of 4.73% and a return on equity of 8.89%. The business's quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.98 EPS. View LHC Group's earnings history. What price target have analysts set for LHCG? 10 equities research analysts have issued 1 year price objectives for LHC Group's shares. Their forecasts range from $120.00 to $220.00. On average, they expect LHC Group's share price to reach $165.67 in the next year. This suggests that the stock has a possible downside of 17.1%. View analysts' price targets for LHC Group. Has LHC Group been receiving favorable news coverage? Headlines about LHCG stock have trended somewhat negative recently, InfoTrie reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. LHC Group earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media coverage about the health services provider a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the immediate future. View the latest news about LHC Group. Are investors shorting LHC Group? LHC Group saw a decrease in short interest in June. As of June 30th, there was short interest totaling 736,500 shares, a decrease of 24.3% from the June 15th total of 973,000 shares. Based on an average daily trading volume, of 436,600 shares, the short-interest ratio is presently 1.7 days. Approximately 2.5% of the company's shares are sold short. View LHC Group's Current Options Chain. Who are some of LHC Group's key competitors? Some companies that are related to LHC Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). View all competitors. What other stocks do shareholders of LHC Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), Home Depot (HD), Alibaba Group (BABA), Cisco Systems (CSCO), CVS Health (CVS), Chevron (CVX), Honeywell International (HON), Intel (INTC), Visa (V) and Walt Disney (DIS). Who are LHC Group's key executives? LHC Group's management team includes the following people: Keith G. Myers, Chairman & Chief Executive OfficerDonald Dwayne Stelly, President & Chief Operating OfficerJoshua L. Proffitt, Chief Financial Officer & Executive Vice PresidentAngie M. Begnaud, Chief Clinical Officer & Executive Vice PresidentBenjamin Doga, Chief Medical Officer What is LHC Group's stock symbol? LHC Group trades on the NASDAQ under the ticker symbol "LHCG." Who are LHC Group's major shareholders? LHC Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Copper Rock Capital Partners LLC (16.76%), Sumitomo Mitsui Trust Holdings Inc. (0.90%), Tributary Capital Management LLC (0.64%), Westwood Management Corp IL (0.56%), Summit Creek Advisors LLC (0.43%) and Redwood Investments LLC (0.33%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View institutional ownership trends for LHC Group. Which major investors are selling LHC Group stock? LHCG stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Janney Montgomery Scott LLC, Tributary Capital Management LLC, First Trust Advisors LP, New York State Teachers Retirement System, Comerica Bank, Westwood Management Corp IL, and Ziegler Capital Management LLC. View insider buying and selling activity for LHC Group. Which major investors are buying LHC Group stock? LHCG stock was bought by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Summit Creek Advisors LLC, Columbus Circle Investors, UBS Group AG, State of Michigan Retirement System, Quantitative Systematic Strategies LLC, Duality Advisers LP, and Dupont Capital Management Corp. View insider buying and selling activity for LHC Group. How do I buy shares of LHC Group? Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is LHC Group's stock price today? One share of LHCG stock can currently be purchased for approximately $199.80. How big of a company is LHC Group? LHC Group has a market capitalization of $6.31 billion and generates $2.08 billion in revenue each year. The health services provider earns $95.73 million in net income (profit) each year or $4.47 on an earnings per share basis. LHC Group employs 30,399 workers across the globe. What is LHC Group's official website? The official website for LHC Group is www.lhcgroup.com. How can I contact LHC Group? LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected] This page was last updated on 8/5/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
